Impact of pre- and post-procedural anemia on the incidence of acute kidney injury and 1-year mortality in patients undergoing transcatheter aortic valve implantation (from the French Aortic National CoreValve and Edwards 2 [FRANCE 2] Registry)

Catheterization and Cardiovascular Interventions

Volumn 85, Issue 7, 2015, Pages 1231-1239

  Arai, Takahide ^a   Morice, Marie Claude ^a   O'Connor, Stephen A ^a   Yamamoto, Masanori ^b,c   Eltchaninoff, Hélène ^d   Leguerrier, Alain ^e   Leprince, Pascal ^f   Laskar, Marc ^g   Iung, Bernard ^h   Fajadet, Jean ⁱ   Prat, Alain ^j   Lièvre, Michel ^k   Donzeau Gouge, Patrick ^a   Chevreul, Karine ^b   Teiger, Emmanuel ^b   Lefèvre, Thierry ^a   Gilard, Martine ^l  

^a INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c Toyohashi Heart Center Toyohashi   (Japan)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e RENNES UNIVERSITY HOSPITAL   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g DUPUYTREN UNIVERSITY HOSPITAL   (France)

^h BICHAT HOSPITAL   (France)

ⁱ CLINIQUE PASTEUR   (France)

^j LILLE UNIVERSITY HOSPITAL   (France)

^k UNIVERSITÉ LYON 1   (France)

^l BREST UNIVERSITY HOSPITAL   (France)

more..

Author keywords

acute kidney injury; anemia; severe symptomatic aortic stenosis; transcatheter aortic valve implantation

Indexed keywords

HEMOGLOBIN; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; AGED; ANEMIA; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FRANCE; HEALTH IMPACT ASSESSMENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPLANT REGISTRY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; AORTA VALVE; AORTIC VALVE STENOSIS; BLOOD; CHI SQUARE DISTRIBUTION; DEVICES; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; KAPLAN MEIER METHOD; METABOLISM; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME FACTOR; VERY ELDERLY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; ANEMIA; AORTIC VALVE; AORTIC VALVE STENOSIS; BIOMARKERS; CARDIAC CATHETERIZATION; CHI-SQUARE DISTRIBUTION; FEMALE; FRANCE; HEART VALVE PROSTHESIS IMPLANTATION; HEMOGLOBINS; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84929708047     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25832     Document Type: Article

References (19)

1. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, et al., Transcatheter aortic valve implantation: Early results of the FRANCE (FRench aortic national CoreValve and edwards) registry. Eur Heart J 2011; 32: 191-197.
2. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, et al., Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
3. Webb J, Cribier A,. Percutaneous transarterial aortic valve implantation: What do we know? Eur Heart J 2011; 32: 140-147.
4. Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP, Thomas M, Kovac J, Spyt T, MacCarthy PA, et al., Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: The U.K. TAVI (united kingdom transcatheter aortic valve implantation) registry. J Am Coll Cardiol 2011; 58: 2130-2138.
5. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, et al., Transcatheter aortic valve implantation: First results from a multi-centre real-world registry. Eur Heart J 2011; 32: 198-204.
6. Nuis RJ, Sinning JM, Rodes-Cabau J, Gotzmann M, van Garsse L, Kefer J, Bosmans J, Yong G, Dager AE, Revilla-Orodea A, et al., Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv 2013; 6: 625-634.
7. Yamamoto M, Hayashida K, Mouillet G, Hovasse T, Chevalier B, Oguri A, Watanabe Y, Dubois-Rande JL, Morice MC, Lefevre T, et al., Prognostic value of chronic kidney disease after transcatheter aortic valve implantation. J Am Coll Cardiol 2013; 62: 869-877.
8. Silverberg DS, Wexler D, Blum M, Wollman Y, Schwartz D, Sheps D, Keren G, Iaina A,. The interaction between heart failure, renal failure and anemia-The cardio-renal anemia syndrome. Blood Purif 2004; 22: 277-284.
9. Miceli A, Romeo F, Glauber M, de Siena PM, Caputo M, Angelini GD,. Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery. J Cardiothorac Surg 2014; 9: 137.
10. Ohno Y, Maekawa Y, Miyata H, Inoue S, Ishikawa S, Sueyoshi K, Noma S, Kawamura A, Kohsaka S, Fukuda K,. Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention. J Am Coll Cardiol 2013; 62: 1260-1266.
11. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, et al., Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366: 1705-1715.
12. Nutritional anaemias. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser 1968; 405: 5-37.
13. Nuis RJ, Rodes-Cabau J, Sinning JM, van Garsse L, Kefer J, Bosmans J, Dager AE, van Mieghem N, Urena M, Nickenig G, et al., Blood transfusion and the risk of acute kidney injury after transcatheter aortic valve implantation. Circ Cardiovasc Interv 2012; 5: 680-688.
14. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, et al., Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: A consensus report from the valve academic research consortium. Eur Heart J 2011; 32: 205-217.
15. Previsdomini M, Stocker R, Corti R, Cerutti B, Perren A,. Time course of hemoglobin concentrations in the intensive care unit in nonbleeding patients with acute coronary syndrome. Am J Cardiol 2007; 100: 579-582.
16. Tamburino C, Barbanti M, Capodanno D, Mignosa C, Gentile M, Aruta P, Pistritto AM, Bonanno C, Bonura S, Cadoni A, et al., Comparison of complications and outcomes to one year of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis. Am J Cardiol 2012; 109: 1487-1493.
17. Tchetche D, Van der Boon RM, Dumonteil N, Chieffo A, Van Mieghem NM, Farah B, Buchanan GL, Saady R, Marcheix B, Serruys PW, et al., Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: Insights from the Pooled-RotterdAm-Milano-toulouse in collaboration plus (PRAGMATIC Plus) initiative. Am Heart J 2012; 164: 402-409.
18. Genereux P, Cohen DJ, Williams MR, Mack M, Kodali SK, Svensson L, Kirtane AJ, Xu K, McAndrew TC, Makkar R, et al., Bleeding complications after surgical aortic valve replacement (SAVR) compared with transcatheter aortic valve replacement (TAVR): Insights from the PARTNER I trial. J Am Coll Cardiol 2014; 63: 1100-1109.
19. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Engoren M, Durham SJ, Shah A,. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: Implications on operative outcome. Crit Care Med 2005; 33: 1749-1756.